Endothelin A Antagonism and Kidney Blood Flow in Pigs
Author Information
Author(s): Johan Fenhammar, Andreas Andersson, Jakob Forestier, Eddie Weitzberg, Alf Sollevi, Hans Hjelmqvist, Robert Frithiof
Primary Institution: Karolinska Institutet, Huddinge, Stockholm, Sweden
Hypothesis
Endothelin mediates renal microcirculatory impairment in endotoxemia through activation of ETA and treatment with TBC 3711, a selective ETA antagonist, would improve renal microcirculation and function.
Conclusion
The study found that endothelin A receptor antagonism attenuates renal medullary blood flow impairment during endotoxemia, but does not improve overall renal function.
Supporting Evidence
- Endothelin-1 levels increased significantly during endotoxemia.
- TBC 3711 treatment reduced the decline in renal medullary blood flow.
- No significant difference in diuresis or creatinine clearance was observed between groups.
Takeaway
This study looked at how a specific drug can help blood flow in the kidneys of pigs that are sick from infection, showing that it helps some parts but not all.
Methodology
The study used a randomized experimental design with anesthetized pigs subjected to endotoxin infusion, comparing those treated with an ETA antagonist to controls.
Potential Biases
Potential bias due to the lack of sham controls and the invasive nature of the procedures.
Limitations
The study was conducted in anesthetized animals, which may affect renal function, and all measurements were performed only on one kidney.
Participant Demographics
Sixteen crossbred female pigs weighing approximately 33.3 kg.
Statistical Information
P-Value
p=0.002
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website